March 14, 2018 / 11:38 AM / 9 months ago

BRIEF-ProMIS Neurosciences Announces Fiscal Year 2017 Annual Results

March 14 (Reuters) - ProMIS Neurosciences Inc:

* PROMIS NEUROSCIENCES ANNOUNCES FISCAL YEAR 2017 ANNUAL RESULTS

* PROMIS NEUROSCIENCES INC - ‍TOP PRIORITY FOR 2018 TO CONTINUE TO PROGRESS DEVELOPMENT OF PMN310 FOR CLINICAL TRIAL INITIATION IN 2019​

* PROMIS NEUROSCIENCES - IN 2018, ‍WILL CONTINUE TO EXPAND PROGRAM TARGETING TDP43 IN ALS AND FTD AND ITS ALPHA-SYNUCLEIN PROGRAM FOR PD​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below